Due to the unprecedented nature of the COVID-19 pandemic, anyone reporting an Adverse Event and/or a Product Complaint via phone, should you receive a network busy signal (ie: if all lines busy/engaged) please continue to try your call throughout the day. Alternatively, you may email your Adverse Event to firstname.lastname@example.org OR Product Complaint to email@example.com, OR medical information request to MedInfo@propharmagroup.com.
PARAMUS, N.J., Oct. 11, 2016 /PRNewswire/ — (WGCC), a wholly owned subsidiary of PharmaSphere, Inc., announced today that it has launched the first and only 400 mcg/4 mL and 1000 mcg/10 mL multi-dose vials. Dexmedetomidine HCl Injection is currently sold as a 2 mL vial by multiple manufacturers. Dexmedetomidine is also available in ready to...Read More